BACKGROUND AND PURPOSE:Tumor location is a significant prognostic factor in glioblastoma, which may reflect the genetic profile of tumor precursor cells. The purpose of the current study was to construct and analyze probabilistic radiographic atlases reflecting preoperative tumor locations and corresponding demographic, "-omic," and interventional phenotypes to provide insight into potential niche locations of glioblastoma cells of origin.

Glioblastoma (GBM) is the most common of all the primary brain tumors with a dismal prognosis. Pediatric GBM, despite being rare, is associated with a relatively better survival than the adults. However, an increased survival could subject these children to some rare events like a spinal metastasis. Herein, we report an interesting case of a 9-year-old boy who was operated on under emergent circumstances for a left fronto-temporo-insular GBM at our institute. A maximal safe resection of the tumor was achieved followed by adjuvant chemoradiation. The boy was doing well in the follow-up visits until about a year and a half after the surgery when he presented again with quadriparesis. On a cervical spine imaging, a circumferential, enhancing mass was seen draped around the cervicothoracic spinal cord, consistent with a spinal subarachnoid (leptomeningeal) metastatic deposit. We discussed the prognosis and the relatives preferred a supportive treatment. The child eventually died after 4 weeks. We discuss the literature on the incidence, pattern, and outcome of spinal metastasis from supratentorial GBM in general and the pediatric population in particular.

Learning Objectives: Percutaneous thoracic duct embolization has been shown to be effective in the treatment of recurrent chylous effusions. Many embolic agents have been described in the successful occlusion of the thoracic duct. In this study, we evaluate the role and efficacy of using EVOH copolymer (Onyx) in the treatment of traumatic chylous pleural effusions. Background: A retrospective review was performed of consecutive patients with post-operative chylous pleural effusions treated with thoracic duct embolization using EVOH copolymer at a single institution from 2012-2014. Demographic data, surgical history, procedure details, and toxicities were systematically reviewed. Clinical Findings/Procedure Details: 4 patients (M¼2) were identified that met inclusion criteria. Median age at treatment was 67. Median follow was 125 days (range 24-246). Two patients had undergone robotic assisted surgery and 2 had undergone open thoracotomy. 3 patients had thoracic duct ligation performed at the time of their initial surgery. Median time from surgery to embolization was 7 days (range 3-15). Daily chest tube drainage range was 150 -2000 ml. All patients underwent bilateral ultrasound guided inguinal nodal lymphangiogram. The thoracic duct was then accessed using a 21 or 22 gauge Chiba needle. A thoracic duct leak was identified in 3 patients. Coils were placed initially in the central duct prior to embolization of the leak limit potential systemic flow. Onyx 34 (ev3 Neurovascular, Irvine, California) was used in 4 patients with additional Onyx 18 in 1 patient for embolization. Volume used was 1-2 ml in all patients. All patients had resolution of the chylous effusion within 1 day of embolization. The subjects were discharged from the hospital between 4-7 days post-procedure. 30 days post-procedure complications included an abdominal wall hematoma in 1 patient who was subsequently started on anticoagulation. No patients developed recurrent chyle leaks during the follow up period. Conclusion and/or Teaching Points: EVOH copolymer is a safe and effective agent for percutaneous thoracic duct embolization. This is the largest reported series to date demonstrating the efficacy of this embolic agent in treating chylous effusions in the post-traumatic setting.

Background: Central tumor location, brain stem involvement, and medulloblastoma have been implicated as risk factors for pediatric postoperative cerebellar mutism syndrome (pCMS) by most researchers. However, conflicting results have been reported for surgical factors, such as the extent of excision, surgical approach, and the need for cerebrospinal fluid diversion. The role of emergency or elective surgery is also not well established. Aim: To assess the role of surgical factors as a risk for pCMS. The secondary variables assessed include patient profile, histopathology, radiological features, and the effect of pCMS on patient survival. Materials and Methods: Overall, 162 consecutively operated patients with posterior fossa tumor (PFT) from July 2012 to March 2020, younger than 16 years of age, were included in the study. The study population was divided into two cohorts: the pCMS group and the non-pCMS group for statistical analysis. A P-value of less than 0.05 was considered statistically significant. Results: In the sample size of 162 patients, 129 patients were included for analysis. There were 11 patients in the pCMS group. Emergency surgery was found to be a significant risk for pCMS (P = 0.021). There was a trend toward statistical significance for the need for preoperative cerebrospinal fluid diversion. The extent of resection and surgical approach were not found to be statistically significant factors. Central tumor location and contrast enhancement were significant radiological risk factors (P < 0.05). Conclusion: Aggressive tumor resection causing iatrogenic injury to the cerebellar circuitry and the brain stem is the most important risk factor for pCMS. Patients with pCMS have adverse survival outcomes.